BDTX
Price
$2.76
Change
+$0.09 (+3.37%)
Updated
Dec 11 closing price
Capitalization
157.25M
96 days until earnings call
Intraday BUY SELL Signals
CGEM
Price
$12.38
Change
-$0.08 (-0.64%)
Updated
Dec 11 closing price
Capitalization
731.36M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs CGEM

Header iconBDTX vs CGEM Comparison
Open Charts BDTX vs CGEMBanner chart's image
Black Diamond Therapeutics
Price$2.76
Change+$0.09 (+3.37%)
Volume$1.09M
Capitalization157.25M
Cullinan Therapeutics
Price$12.38
Change-$0.08 (-0.64%)
Volume$891.2K
Capitalization731.36M
BDTX vs CGEM Comparison Chart in %
BDTX
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDTX vs. CGEM commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and CGEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BDTX: $2.76 vs. CGEM: $12.38)
Brand notoriety: BDTX and CGEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 85% vs. CGEM: 66%
Market capitalization -- BDTX: $157.25M vs. CGEM: $731.36M
BDTX [@Biotechnology] is valued at $157.25M. CGEM’s [@Biotechnology] market capitalization is $731.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileCGEM’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • CGEM’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while CGEM’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 6 bearish.
  • CGEM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а +1.85% price change this week, while CGEM (@Biotechnology) price change was +17.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was +4.75%, and the average quarterly price growth was +65.86%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

CGEM is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($731M) has a higher market cap than BDTX($157M). BDTX YTD gains are higher at: 28.972 vs. CGEM (1.642). BDTX has higher annual earnings (EBITDA): 5.05M vs. CGEM (-234.39M). CGEM has more cash in the bank: 265M vs. BDTX (143M). CGEM has less debt than BDTX: CGEM (1.52M) vs BDTX (20.8M). BDTX has higher revenues than CGEM: BDTX (70M) vs CGEM (0).
BDTXCGEMBDTX / CGEM
Capitalization157M731M21%
EBITDA5.05M-234.39M-2%
Gain YTD28.9721.6421,764%
P/E Ratio7.46N/A-
Revenue70M0-
Total Cash143M265M54%
Total Debt20.8M1.52M1,369%
FUNDAMENTALS RATINGS
BDTX: Fundamental Ratings
BDTX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXCGEM
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FICHX15.330.11
+0.72%
Cantor Fitzgerald Large Cap Fcs Cl Inst
LSOFX19.020.09
+0.48%
LS Opportunity Fund Institutional Class
MRGHX57.320.27
+0.47%
MFS Core Equity R3
NSEPX24.300.06
+0.25%
Columbia Cornerstone Equity Inst
FSYNX11.76N/A
N/A
Fidelity Advisor Sustainable EM Eq M

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+3.37%
RLAY - BDTX
46%
Loosely correlated
+2.64%
CRBU - BDTX
43%
Loosely correlated
-2.11%
MLTX - BDTX
42%
Loosely correlated
-3.70%
VYGR - BDTX
39%
Loosely correlated
-0.23%
IDYA - BDTX
39%
Loosely correlated
-0.24%
More

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with RLAY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-0.64%
RLAY - CGEM
43%
Loosely correlated
+2.64%
NRIX - CGEM
43%
Loosely correlated
-2.75%
ORMP - CGEM
42%
Loosely correlated
+4.66%
SYRE - CGEM
42%
Loosely correlated
-0.87%
DNLI - CGEM
41%
Loosely correlated
-1.14%
More